Women Want a Choice Between Vaginal HPV Self-Sampling and Clinician Screen
THURSDAY, Oct. 24, 2024 -- Most women would like a choice between vaginal human papillomavirus (HPV) self-sampling and traditional clinician screening, although nearly half would prefer a recommendation, according to a study published online in the October issue of the Journal of Medical Screening.
Laura Marlow, Ph.D., from Queen Mary University of London, and colleagues examined attitudes toward a choice and anticipated future preference among women who had collected a vaginal self-sample at home alongside their usual cervical screen in 38 general practices in England. A total of 2,323 women completed a survey after collecting a self-sample and having a clinician screen.
The researchers found that 85 percent of participants felt they would like a choice between self-sampling and clinician screening, and 72 percent felt that this would improve screening for them. Overall, 23 percent felt it would be difficult to choose, 15 percent would worry about making a choice, and 48 percent would prefer a recommendation. Women with fewer qualifications were significantly more likely than those with degree-level education to say they would worry about having a choice or would not want a choice. If offered a choice in the future, 69 percent of women said they would choose to self-sample at home.
"This suggests an urgent need to develop and test different ways of offering this choice so that optimal messaging can be used in any roll-out or evaluation of HPV self-sampling choice in the United Kingdom and elsewhere," the authors write.
One author disclosed ties to Hologic, manufacturers of an HPV self-sample kit.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Read this next
Lung Cancer Screening Beneficial to Age 80 for Candidates Fit for Surgery
FRIDAY, Sept. 12, 2025 -- People aged 75 to 80 years at last screen who are diagnosed with screen-detected lung cancer (LC) have lower overall survival, but those undergoing...
Sex Differences Seen in Characteristics, Course of Schizophrenia, Bipolar Disorder
FRIDAY, Sept. 12, 2025 -- Significant sex differences are seen in the characteristics and course of schizophrenia (SZ) and bipolar disorder (BD), according to a study published...
Potentially Inappropriate Medications Linked to Frailty at Cancer Diagnosis
FRIDAY, Sept. 12, 2025 -- For patients with newly diagnosed cancer, an increasing number of potentially inappropriate medications (PIMs), as identified by the Geriatric Oncology...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.